Pharma Journalist -

Clinical biopharmaceutical company, Liquidia dedicated to accelerate the performance of precision medicine by accurately engineering drug particles announces to commence the evolution…
Read More...

Pharmaceutical Product Development, LLC asserts Colin Hill, an acclaimed name in the health care technology and a connoisseur in precision medicine to its board of directors. He is…
Read More...

Leading venture backed microbiome company growing novel molecular therapeutics based on the human microbiome, asserted that it intends to enter into an agreement with Paragon…
Read More...

Advanced precision medicine CIRCULOGENE through its molecular genetics testing enters into an international licensing agreement with turkey based CIRCULOGENE Saglik. As per the terms…
Read More...

CanniMed Therapeutics Inc’s wholly owned subsidiary Sub Terra LLC moves to produce and process medical cannabis through its State of Michigan licenses application. The company has…
Read More...

Ophthalmic medical technology company Glaukos Corporation committed to the development of world-class products aiming to revolutionise the treatment of Glaucoma declared that it has…
Read More...

ANI Pharmaceuticals announced that it has acquired the NDAs and U.S. rights to market ATACAND, ATACAND HCT, ARIMIDEX, and CASODEX from AstraZeneca for $46.5 million in cash, royalties,…
Read More...

HyLeukin is an immuno-oncology agent comprised of an optimally engineered Interleukin-7 (IL-7) molecule based on Genexine's proprietary long-acting platform technology. Genexine…
Read More...

Mallinckrodt announced that they have entered into an agreement under which Mallinckrodt will acquire Sucampo, including its commercial and development assets. The transaction was…
Read More...

Teva Pharmaceutical Industries Ltd., announced the exclusive launch of a generic version of Reyataz®1 (atazanavir) capsules in the U.S. Atazanavir sulfate capsules are a protease…
Read More...